SALVATORI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 3.181
AS - Asia 2.093
EU - Europa 1.520
SA - Sud America 406
AF - Africa 42
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.249
Nazione #
US - Stati Uniti d'America 3.107
SG - Singapore 782
CN - Cina 727
BR - Brasile 365
IT - Italia 365
DE - Germania 240
PL - Polonia 228
UA - Ucraina 190
HK - Hong Kong 182
GB - Regno Unito 128
VN - Vietnam 125
TR - Turchia 91
FI - Finlandia 75
SE - Svezia 68
RU - Federazione Russa 52
FR - Francia 48
ID - Indonesia 39
CA - Canada 37
IN - India 30
MX - Messico 29
NL - Olanda 24
ES - Italia 23
JP - Giappone 22
ZA - Sudafrica 21
AR - Argentina 19
IR - Iran 19
BE - Belgio 16
PK - Pakistan 15
CH - Svizzera 14
BD - Bangladesh 13
LT - Lituania 12
CZ - Repubblica Ceca 11
AE - Emirati Arabi Uniti 9
EC - Ecuador 9
IQ - Iraq 9
RO - Romania 9
KE - Kenya 6
AT - Austria 5
AU - Australia 5
CO - Colombia 5
DZ - Algeria 4
EG - Egitto 4
MY - Malesia 4
TW - Taiwan 4
JO - Giordania 3
KR - Corea 3
KZ - Kazakistan 3
MA - Marocco 3
TN - Tunisia 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
GE - Georgia 2
HN - Honduras 2
PA - Panama 2
PT - Portogallo 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
BZ - Belize 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
IE - Irlanda 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 7.249
Città #
Singapore 448
Ashburn 368
Beijing 318
Woodbridge 290
Warsaw 224
Chandler 219
Jacksonville 204
Hong Kong 181
Santa Clara 180
Houston 169
Ann Arbor 138
Fairfield 137
Ferrara 99
Wilmington 92
Bologna 81
Los Angeles 74
Nanjing 71
New York 67
Munich 60
Seattle 55
Izmir 53
Ho Chi Minh City 47
Princeton 46
Milan 45
Dallas 43
Addison 41
Cambridge 40
Shanghai 37
Boardman 35
São Paulo 33
Hanoi 30
Bremen 28
Jakarta 27
Shenyang 23
Turku 23
Tokyo 20
Brooklyn 19
Buffalo 19
Hefei 19
Mexico City 18
Redwood City 18
San Francisco 18
Auburn Hills 16
San Diego 16
Brussels 15
Denver 15
London 15
Toronto 15
Chicago 14
Falls Church 14
Hebei 14
Dearborn 13
Helsinki 13
Nanchang 13
Rio de Janeiro 13
Jiaxing 12
Poplar 12
Stockholm 12
Tianjin 12
Changsha 11
Chennai 11
Moscow 11
Orem 11
Phoenix 11
San Jose 11
Boston 10
Brno 10
Johannesburg 10
Padova 10
Haiphong 9
Manchester 9
Atlanta 8
Brasília 8
Guangzhou 8
Lauterbourg 8
Montreal 8
Mountain View 8
Rome 8
Zhengzhou 8
Ankara 7
Belo Horizonte 7
Falkenstein 7
Frankfurt am Main 7
Leiden 7
Ningbo 7
Da Nang 6
Jinan 6
Lanzhou 6
Santo André 6
Cattolica 5
Des Moines 5
Fortaleza 5
Manaus 5
Nuremberg 5
Querétaro 5
Uberlândia 5
Cagliari 4
Campinas 4
Caxias do Sul 4
Curitiba 4
Totale 4.696
Nome #
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 239
Strategies for the adult haemoglobin (HbA) production in β0-thalassemia patients 236
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 226
SPR-based non-invasive prenatal testing for fetal sex determination 216
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 206
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 188
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 185
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 183
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 182
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 169
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 165
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 162
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 149
Cellular biosensors for the identification of fetal hemoglobin inducers 145
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 145
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 144
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 142
Development and molecular characterization of transgenic mice for beta-thalassemia 139
Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects 139
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 132
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 130
Gene therapy combined with HbF induction in beta-thalassemia 130
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 125
Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris 124
Gene therapy and fetal hemoglobin induction 117
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells 116
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 113
circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis 112
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 109
null 107
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 107
LINE-1 global DNA methylation, iron homeostasis genes, sex and age in sudden sensorineural hearing loss (SSNHL) 106
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 106
Genetic Architecture of the 3D-Fibrin Meshwork in Pregnancy Maintenance 105
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 104
PNA-mediated alteration of mRNA splicing 103
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 103
Evidences for miRNA regulation of BCL11A gene expression 102
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 101
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 97
Readthrough of the premature stop codon beta039-thalassemia 97
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 97
DNA Methylation Signature of LINE1, SATα and Alu elements in Alzheimer’s Disease: Tracing NeuroEpigenetics by a Sex-specific Approach 91
Generation and molecular characterization of a transgenic mouse line carrying a mutated human β°39 thalassemia β-globin gene 91
Production of a cellular model for the screening of inducers of fetal haemoglobin 90
UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation 90
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 86
null 85
PLCB3 Loss of Function Reduces Pseudomonas aeruginosa-Dependent IL-8 Release in Cystic Fibrosis 83
Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy 80
Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia 75
null 75
Novel Psychoactive Substances (NPS) Footprint by Cytokine Release and Volatilome Profile: Advances in Clinical Toxicology 69
null 69
Telomere Length and Global DNA Methylation as Predictors of Pregnancy Outcome: Insights into Reproductive Medicine 66
Telomere Length and Global DNA Methylation in Pregnancy Loss 63
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 63
Host Genetics versus Environment (Thrifty Genes) in COVID-19 severity and progression by PCA-based approaches 62
Peptide nucleic acids targeting the murine beta-globin mRNAs selectively inhibit hemoglobin production in Murine Erythroleukemia (MEL) cells. 60
Tobramycin is a suppressor of premature termination codons. 47
LINE-1 Methylation sustains telomere length in pregnant women: effects on pregnancy failure 42
null 40
Effect of infections, DNA methylation and telomere length on frailty trajectories in hospitalized older patients: the INFRAGEN study protocol 33
Prognostic Value of the Stromal Cell-Derived Factor 1 3prime prime or minuteA Mutation in Pediatric Human Immunodeficiency Virus Type 1 Infection 7
Totale 7.370
Categoria #
all - tutte 34.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 685
Totale 35.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 58 22 56 25 66 124 56
2021/2022469 45 39 13 15 29 23 22 18 15 44 39 167
2022/2023496 57 53 11 63 94 63 28 40 41 9 21 16
2023/2024385 22 40 19 7 32 64 56 25 5 18 23 74
2024/20251.485 56 34 104 86 130 113 52 64 266 164 232 184
2025/20262.128 420 203 312 469 647 77 0 0 0 0 0 0
Totale 7.370